BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND Beta-hCG
35 results:

  • 1. Urothelial carcinoma of the prostate with raised β-hCG levels: a case report.
    Sołek J; Kalwas M; Sobczak M; Dębska-Szmich S; Kupnicki P; Jesionek-Kupnicka D
    J Med Case Rep; 2022 Jun; 16(1):238. PubMed ID: 35701835
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
    Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
    Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
    Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multiplex measurement of twelve tumor markers using a GMR multi-biomarker immunoassay biosensor.
    Gao Y; Huo W; Zhang L; Lian J; Tao W; Song C; Tang J; Shi S; Gao Y
    Biosens Bioelectron; 2019 Jan; 123():204-210. PubMed ID: 30174274
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents.
    Higgins V; Fung AWS; Chan MK; Macri J; Adeli K
    Clin Chem Lab Med; 2018 Jan; 56(2):327-340. PubMed ID: 28723610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
    Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
    Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [National external quality assessment and comparability of assays for tumor markers measurements].
    Zhang JT; Zhang CB; Ma R; Zhao HJ; Wang J; Wang ZG; Chen WX
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):993-7. PubMed ID: 20646652
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples.
    Liew M; Groll MC; Thompson JE; Call SL; Moser JE; Hoopes JD; Voelkerding K; Wittwer C; Spendlove RS
    Biotechniques; 2007 Mar; 42(3):327-8, 330-3. PubMed ID: 17390539
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
    Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
    Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Diagnostic management of inaugurable metastases].
    Penel N
    Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?
    Daja MM; Aghmesheh M; Ow KT; Rohde PR; Barrow KD; Russell PJ
    Mol Urol; 2000; 4(4):421-7. PubMed ID: 11156711
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
    Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
    Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Vaccines for control of fertility and hormone-dependent cancers.
    Talwar GP
    Immunol Cell Biol; 1997 Apr; 75(2):184-9. PubMed ID: 9107573
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.